• Local Treatment of Diabetic Foot Ulcers by Hyperoil™: An Unexpected Outcome
    Ahmed Salah Arafa *, Ahmed yehia , Alaa fiad
  • Evaluation of the Effect of Pulsed Electromagnetic Field Therapy in the Treatment of Chronic Wounds
    1Magdy Salah El-Din Hussain, 1Hisham Wefky Anwar, 2Mostafa Mahmoud El Nakib, 1Amr Essam Mosaad*
  • Sandwich Vacuum Bogota versus Conventional Bogota Bag as Temporary Abdominal Closure (TAC) Techniques
    Doaa Ahmed Mansour M.D., FRCS Eng
  • Bleomycin Sclerotherapy for Management of Cervicofacial and Axillary Lymphatic Malformations in Children
    Moutaz Ragab1,Mohamed Hamed Abouelfadl1, Mahmoud M. Marei 1
  • Efficacy and Safety of Systemic Beta Blockers for the Treatment of Infantile Hemangioma
    Moutaz Ragab, Mahmoud M. Marei ,Mohamed Hamed Abouelfadl
  • Comparison between Mass Ligation of Testicular Vessels versus Testicular Artery Sparing during Laparoscopic Bilateral Varicocelectomy
    Wadie Boshra MD, MRCS, Mohammed Attia Elsayed MD, Ahmed S. M. Omar MD.
  • Study of Splenic Injury in Belharzail Hepatic Fibrosis Patients Subjected To Blunt Abdominal Trauma
    Mahmoud Alhussinia, M. Ashraf Balbaab, Ahmed Tarek Awada, Tamer Abdelbakia
  • Choledochal Cysts in Adults: The Clinicopathological Features and Surgical Outcomes in a Single Institute.
    Ahmed El-Gendi1, Mohamed El-Shafei2, Essam Bedewy3
  • Banded Versus Non-Banded Sleeve Gastrectomy “Comparative Study”
    Elsobky A, MD
  • Ultrasound guided sclerotherapy injection of subulcer venous plexus for treatment of chronic venous ulcer
    Ahmed Sawaby1, Islam Atta2, Amr El Abd3,Mohsen Ahmed Abdelmohsen4
  • Impact of Roux-en-Y gastric bypass and sleeve gastrectomy on three common co-morbidities in morbidly obese Egyptian patients: A randomized comparative study
    Ayman M. A. Osman1 MD, MRCS (Eng); Hytham H. Mohey1 M.Sc.; Ahmed M. Ghobashy1 MD
  • Is transfer of surgically risk necrotizing enterocolitis to tertiary center is important from the start?
    Nezar A. Abo Halawa1*, Ahmed El-Abd Ahmed2, Sawsan A. Elkhateeb3, Galal H. Galal3
  • Delayed Primary Closure of Exomphalos Major in a Limited Resource Area
    Nezar A. Abo Halawa1*, Mohamed Yousef Batikhe2
  • Bilateral Thoracoscopic Sympathectomy for Primary Palmar Hyperhidrosis, Which Level: T3 or T4?
    Wadie Boshra MD, MRCS, Abdallah Hamed Ibrahim Khalil MD, Fawzy Salah Fawzy MD, MRCS
  • Comparative study between Tunneled central venous catheter and Infraclavicular Arterio-arterial Prosthetic loop as an access for Hemodialysis in End stage renal disease (ESRD)
    Hussein Ali Mustafa Abdel-Motaleb, Mohammed Ahmed Mohammed Ismail, Islam Mohamed Nabil Atta & Ahmed Mohammed Ahmed Abdel-Rahim*
  • Significance of Metastatic Positive Lateral Group of Lymph Nodes in Patients Undergoing Axillary Dissection for Breast Carcinoma
    Reem Mohamed Ali Abd El Reheem El Masry1, Sameh Abd Allah Maaty2, Anwar A. El Shenawy3, Fawzy Salah Fawzy2

    • Bleomycin Sclerotherapy for Management of Cervicofacial and Axillary Lymphatic Malformations in Children

    Moutaz Ragab1,Mohamed Hamed Abouelfadl1, Mahmoud M. Marei 1
    Department of General Surgery, Pediatric Surgery Unit, Cairo University Specialized Pediatric Hospital (CUSPH), Faculty of Medicine (Kasr Alainy), Cairo University.

    Background and Aim: Lymphatic malformationscan result in severe functional and aesthetic disorders, due to their progressive growth and affinity to occur in challenging anatomical regions as the head and neck region and the axilla. Intralesional sclerotherapy may serve as a single treatment or as an adjunct to surgery.This study presents our early experience with intralesional bleomycin injection in the management of axillary and cervicofacial Lymphatic malformations, over an initial period of 12 months. Methods: This prospective study was conductedat the department of Pediatric Surgery of Cairo University Specialized Pediatric Hospital (CUSPH) and included 8 patients whopresented with lymphatic malformations and were all treated with intralesional bleomycin injection. The dose of bleomycin inject was adjusted to 0.5 IU/kg/injection, with 4-weeks intervals, for 3 – 5 cycles. Results: The median age at inclusion and initiation of treatment was 3.2 years.The average number of sessions was 3.5 ± 0.5. Overall, a satisfactory response was detected in 87.5% of the cases (n = 7), among them one case had recurrence. No systemic adverse effects were noted. Conclusion: Intralesional Bleomycin injection is a safe and effective modality for treating cervicofacial and axillary lymphatic malformations in the pediatric age group. Keywords: Bleomycin; Sclerotherapy; Intralesional Injection; LymphaticMalformations.

    Full Text